Literature DB >> 18417583

Infection with Vpr-positive human immunodeficiency virus type 1 impairs NK cell function indirectly through cytokine dysregulation of infected target cells.

Biswanath Majumder1, Narasimhan J Venkatachari, Shaylee O'Leary, Velpandi Ayyavoo.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) infection has been implicated in impairing various aspects of NK cell function in viremic condition, and several viral factors contribute to these defects. Here, we evaluated the effect of HIV-1 Vpr on NK cell cytolytic function and cytokine (gamma interferon [IFN-gamma]) production in the context of infection and exposure. Our data indicate that NK cells derived from a peripheral blood mononuclear cell culture infected in vitro with HIV-1 vpr(+) virus or exposed to recombinant Vpr protein exhibited reduced target cell killing in conjunction with diminished expression of CD107a and reduced IFN-gamma production compared to their Vpr-negative counterparts. This Vpr-induced NK cell defect is in part through differential regulation of interleukin-12 and transforming growth factor beta production by the infected target cells and concomitant activation of Smad3 signaling pathway. Collectively, these results illustrate the ability of Vpr to impair NK cell-mediated innate immune functions indirectly by dysregulating multiple cytokines in the infected target cells, thus increasing disease severity and affecting the final outcome in HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18417583      PMCID: PMC2446960          DOI: 10.1128/JVI.01979-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro.

Authors:  Karuppiah Muthumani; Daniel S Hwang; Andrew Y Choo; Shanmugam Mayilvahanan; Nathanael S Dayes; Khanh P Thieu; David B Weiner
Journal:  Int Immunol       Date:  2004-12-20       Impact factor: 4.823

2.  Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape.

Authors:  Biswanath Majumder; Michelle L Janket; Elizabeth A Schafer; Keri Schaubert; Xiao-Li Huang; June Kan-Mitchell; Charles R Rinaldo; Velpandi Ayyavoo
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Kinetics of in vitro natural killer activity against K562 cells as detected by flow cytometry.

Authors:  L Zamai; A R Mariani; G Zauli; L Rodella; R Rezzani; F A Manzoli; M Vitale
Journal:  Cytometry       Date:  1998-08-01

4.  NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand.

Authors:  Vincent Vieillard; Jack L Strominger; Patrice Debré
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-26       Impact factor: 11.205

Review 5.  HIV's evasion of the cellular immune response.

Authors:  K L Collins; D Baltimore
Journal:  Immunol Rev       Date:  1999-04       Impact factor: 12.988

6.  Dendritic and natural killer cell subsets associated with stable or declining CD4+ cell counts in treated HIV-1-infected children.

Authors:  L Azzoni; R M Rutstein; J Chehimi; M A Farabaugh; A Nowmos; L J Montaner
Journal:  J Infect Dis       Date:  2005-03-30       Impact factor: 5.226

7.  Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections.

Authors:  Ute-Christiane Meier; Rachel E Owen; Elizabeth Taylor; Andrew Worth; Nikolai Naoumov; Christian Willberg; Kwok Tang; Phillipa Newton; Pierre Pellegrino; Ian Williams; Paul Klenerman; Persephone Borrow
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

8.  Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.

Authors:  Domenico Mavilio; Gabriella Lombardo; Janet Benjamin; Diana Kim; Dean Follman; Emanuela Marcenaro; M Angeline O'Shea; Audrey Kinter; Colin Kovacs; Alessandro Moretta; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

9.  Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA.

Authors:  Betty Poon; Michael A Chang; Irvin S Y Chen
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

10.  Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells.

Authors:  Yenan T Bryceson; Michael E March; Domingo F Barber; Hans-Gustaf Ljunggren; Eric O Long
Journal:  J Exp Med       Date:  2005-10-03       Impact factor: 14.307

View more
  16 in total

1.  Retrocyclin RC-101 blocks HIV-1 transmission across cervical mucosa in an organ culture.

Authors:  Phalguni Gupta; Deena Ratner; Ming Ding; Bruce Patterson; Lisa C Rohan; Todd A Reinhart; Velpandi Ayyavoo; Xioli Huang; Dorothy L Patton; Bharat Ramratnam; Alexander M Cole
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-15       Impact factor: 3.731

Review 2.  Natural killer cells in immunodefense against infective agents.

Authors:  Nicolas Zucchini; Karine Crozat; Thomas Baranek; Scott H Robbins; Marcus Altfeld; Marc Dalod
Journal:  Expert Rev Anti Infect Ther       Date:  2008-12       Impact factor: 5.091

Review 3.  The functions of the HIV1 protein Vpr and its action through the DCAF1.DDB1.Cullin4 ubiquitin ligase.

Authors:  Laurieann Casey; Xiaoyun Wen; Carlos M C de Noronha
Journal:  Cytokine       Date:  2010-03-27       Impact factor: 3.861

4.  HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing.

Authors:  Jonathan Richard; Sardar Sindhu; Tram N Q Pham; Jean-Philippe Belzile; Eric A Cohen
Journal:  Blood       Date:  2009-12-14       Impact factor: 22.113

5.  Sensing of HIV-1 Infection in Tzm-bl Cells with Reconstituted Expression of STING.

Authors:  Maud Trotard; Nikolaos Tsopoulidis; Nadine Tibroni; Joschka Willemsen; Marco Binder; Alessia Ruggieri; Oliver T Fackler
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

Review 6.  Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr?

Authors:  Diana Ayinde; Claire Maudet; Catherine Transy; Florence Margottin-Goguet
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

7.  Decreased NK cell frequency and function is associated with increased risk of KIR3DL allele polymorphism in simian immunodeficiency virus-infected rhesus macaques with high viral loads.

Authors:  Pavel Bostik; Jaruda Kobkitjaroen; Weining Tang; Francois Villinger; Lara E Pereira; Dawn M Little; Susan T Stephenson; Mark Bouzyk; Aftab A Ansari
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

8.  Pharmacologic Inhibition of Nedd8 Activation Enzyme Exposes CD4-Induced Epitopes within Env on Cells Expressing HIV-1.

Authors:  Andrey Tokarev; Charlotte Stoneham; Mary K Lewinski; Amey Mukim; Savitha Deshmukh; Thomas Vollbrecht; Celsa A Spina; John Guatelli
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

9.  HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response.

Authors:  Jeffrey Ward; Zachary Davis; Jason DeHart; Erik Zimmerman; Alberto Bosque; Enrico Brunetta; Domenico Mavilio; Vicente Planelles; Edward Barker
Journal:  PLoS Pathog       Date:  2009-10-02       Impact factor: 6.823

10.  Immune and hemorheological changes in chronic fatigue syndrome.

Authors:  Ekua W Brenu; Donald R Staines; Oguz K Baskurt; Kevin J Ashton; Sandra B Ramos; Rhys M Christy; Sonya M Marshall-Gradisnik
Journal:  J Transl Med       Date:  2010-01-11       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.